Stonington, CT, United States of America

Anton Franz Joseph Fliri

USPTO Granted Patents = 8 (Patent Applications = 10)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Norwich, CT (US) (2002)
Stonington, CT (US) (2003 - 2021)

Company Filing History:

Years Active: 2002-2021

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11120346 - Method and descriptors for comparing object-induced information flows in a plurality of interaction networks (2021-09-14),

2. 10072018 - Compounds for treatment of pain (2018-09-11),

3. 9487531 - Compounds for treatment of pain (2016-11-08),

4. 8686043 - Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof (2014-04-01),

5. 6552015 - Azabicycloalkane derivatives and therapeutic uses thereof (2003-04-22),

6. 6531468 - Diazabicyclooctane derivatives and therapeutic uses thereof (2003-03-11),

7. 6521630 - Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof (2003-02-18),

8. 6372762 - Substituted bicyclic derivatives for treating central nervous system disorders (2002-04-16),

Title: The Innovative Journey of Anton Franz Joseph Fliri

Introduction

Anton Franz Joseph Fliri, based in Stonington, Connecticut, is a notable inventor known for his contributions to various fields through his innovative patents. With a total of eight patents to his name, Fliri has developed methods and compounds that have the potential to impact technology and medicine significantly.

Latest Patents

Among Fliri's latest inventions is a groundbreaking patent titled "Method and Descriptors for Comparing Object-Induced Information Flows in a Plurality of Interaction Networks." This method offers a sophisticated approach to tracking information flows through multiple network systems. It involves the selection of primary and secondary network systems, identification of network nodes, and the determination of interaction frequencies between objects and the nodes. This innovation underscores his ability to create practical solutions for complex network interactions.

Another noteworthy patent is centered on "Compounds for Treatment of Pain." This patent outlines innovative quaternary ammonium derivatives of opioid drugs like hydrocodone, hydromorphone, and oxycodone. The formulations developed aim to provide a controlled release of pain medication, enhancing patient care and treatment options.

Career Highlights

Throughout his career, Anton Fliri has worked with prominent organizations, including Pfizer Corporation and Biopharma Works LLC. His tenure at these companies has allowed him to hone his skills in pharmaceuticals and biopharmaceutical research, contributing to the development of effective treatments and technologies.

Collaborations

On his journey, Fliri has collaborated with talented individuals such as Randall James Gallaschun and Todd William Butler. These collaborations have further enriched his experience and have proved beneficial in the advancement of his innovative projects.

Conclusion

Anton Franz Joseph Fliri's contributions to innovation showcase his dedication and expertise in creating meaningful solutions for the healthcare and technology sectors. With multiple patents under his belt, Fliri continues to be a significant figure in the world of invention, making strides that pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.